Ripple DRC Ph 2 Evaluation of Safety and Efficacy of IBE-814 IVT Implant - A Sustained, Low Dose Dexamethasone Therapy for the Treatment of Patients with Diabetic Macular Edema (DMO) and Macular Edema due to Retinal Vein Occlusion (RVO).
Research Grant
Administered By
Ophthalmology
Awarded By
Ripple Therapeutics
Start Date
September 15, 2020
End Date
September 30, 2024
Administered By
Ophthalmology
Awarded By
Ripple Therapeutics
Start Date
September 15, 2020
End Date
September 30, 2024